ALPS Advisors’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-129,409
| Closed | -$1.54M | – | 894 |
|
|
2020
Q3 | $1.54M | Sell |
129,409
-8,447
| -6% | -$101K | 0.02% | 265 |
|
|
2020
Q2 | $2.21M | Sell |
137,856
-27,719
| -17% | -$445K | 0.03% | 229 |
|
|
2020
Q1 | $2.57M | Sell |
165,575
-17,809
| -10% | -$276K | 0.04% | 188 |
|
|
2019
Q4 | $4.51M | Buy |
183,384
+1,834
| +1% | +$45.1K | 0.04% | 166 |
|
|
2019
Q3 | $1.87M | Sell |
181,550
-8,575
| -5% | -$88.5K | 0.01% | 215 |
|
|
2019
Q2 | $2.39M | Buy |
+190,125
| New | +$2.39M | 0.02% | 212 |
|
|
2018
Q4 | – | Sell |
-122,992
| Closed | -$1.3M | – | 972 |
|
|
2018
Q3 | $1.3M | Buy |
122,992
+22,150
| +22% | +$235K | 0.01% | 317 |
|
|
2018
Q2 | $1.37M | Buy |
100,842
+7,918
| +9% | +$107K | 0.01% | 280 |
|
|
2018
Q1 | $1.65M | Buy |
92,924
+16,151
| +21% | +$287K | 0.01% | 230 |
|
|
2017
Q4 | $964K | Buy |
76,773
+19,301
| +34% | +$242K | 0.01% | 269 |
|
|
2017
Q3 | $1.1M | Buy |
57,472
+4,797
| +9% | +$91.4K | 0.01% | 234 |
|
|
2017
Q2 | $795K | Buy |
52,675
+2,769
| +6% | +$41.8K | 0.01% | 266 |
|
|
2017
Q1 | $856K | Sell |
49,906
-5,842
| -10% | -$100K | 0.01% | 231 |
|
|
2016
Q4 | $675K | Sell |
55,748
-18,138
| -25% | -$220K | 0.01% | 248 |
|
|
2016
Q3 | $727K | Sell |
73,886
-6,501
| -8% | -$64K | 0.01% | 237 |
|
|
2016
Q2 | $823K | Buy |
+80,387
| New | +$823K | 0.01% | 213 |
|